Menatetrenone
AssetAlso called Vitamin K2, menaquinone, phylloquinone, KAYTWO
Cofactor for gamma-glutamyl carboxylase essential for activating vitamin K-dependent proteins
- Stage
- Phase 3
- Modality
- Supplement
- Target
- Not known
- 3
- Indications
- 22
- Trials
- 2
- Developers
Named in the news on Nov 7, 2026. youtube.com
Indications
3Osteoporosis
Phase 3, Completed, NCT00548509, clinicaltrials.gov, Oct 22, 2026
Postmenopausal osteoporosis
Phase 3, Completed, NCT00165698, clinicaltrials.gov, Oct 31, 2026
Thrombosis
Phase 2, Completed, NCT01533441, clinicaltrials.gov, Oct 31, 2026
In the full profile
- Target and mechanism3
- Owner and partners2
- Trials22
- Evidence for its targets3
- Competitors3
- Signals15
Every asset’s record: target, stage, trials and the evidence behind it.